Clinical Trial Update: Adalimumab Microneedles in Healthy Volunteers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update of adalimumab delivered via microneedles in healthy volunteers (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Injection Site Pain
• Pain

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Centre for Human Drug Research, Netherlands | Conditions: Pain, Injection Site | Phase 1, Phase 2 | Status: COMPLETED